Introduction: Chronic obstructive pulmonary disease (COPD) is currently the fourth-leading cause of mortality and the twelfth-leading cause of disability, and by 2020 it is expected to be the third-leading cause of death and the fifth-leading cause of disability worldwide (1, 2). The diagnosis of COPD largely relies on a history of exposure to noxious stimuli (mainly cigarette smoke) and abnormal lung function test results. Currently, CT is most widely used for radiological disease severity assessment in COPD, and in clinical and academic practice, and hyperpolarized noble gas MR imaging and O2-enhanced MR imaging have been suggested as new techniques in this setting in the last decade. Recently, several investigators have tried to determine the utility of regional T2* measurement in the lung for assessment of pulmonary diseases in animal studies (3, 4). We hypothesized that direct T2* measurement in the lung at 3.0 T MR system has a potential role to play as a method for pulmonary functional loss assessment and clinical stage classification as well as thin-section MDCT. The purpose of this study was to determine the capability of pulmonary MR imaging with ultra-short TEs (UTEs) in a 3.0 T system for pulmonary functional assessment and clinical stage classification in smokers. Materials and Methods: 40 smokers without and with COPD (24 men and 16 women; mean age 68 years) underwent thin-section MDCT, MRI with UTE (UTE-MRI) for quantitative T2* measurement at 3T MRI (Gyroscan Achieva 3T, Best, the Netherlands) and pulmonary functional measurements (FEV 1 /FVC%, FEV 1 % and %DL CO /V A ). All subjects were classified into five groups according to the results of the pulmonary function test and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines (5): 'smokers without COPD (n=9)', 'with mild COPD (n=12)', 'with moderate COPD (n=15)', and 'with severe or very severe COPD (n=4)' groups.
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